Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Colorcon
Merck
Chubb
Medtronic
Julphar
Farmers Insurance
Boehringer Ingelheim
Citi

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,376,505

« Back to Dashboard

Which drugs does patent 9,376,505 protect, and when does it expire?

Patent 9,376,505 protects INJECTAFER and is included in one NDA.

This patent has forty-one patent family members in twenty-eight countries.
Summary for Patent: 9,376,505
Title:Aqueous iron carbohydrate complexes, their production and medicaments containing them
Abstract: A water soluble iron carbohydrate complex obtainable from an aqueous solution of iron(III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, a process for its production and a medicament for the treatment and prophylaxis of iron deficiency conditions.
Inventor(s): Geisser; Peter (St. Gallen, CH), Philipp; Erik (Arbon, CH), Richle; Walter (Gossau, CH)
Assignee: VIFOR (INTERNATIONAL) AG. (St. Gallen, CH)
Application Number:13/556,733
Patent Claim Types:
see list of patent claims
Compound; Formulation; Dosage form;

Drugs Protected by US Patent 9,376,505

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Luitpold Pharms Inc INJECTAFER ferric carboxymaltose INJECTABLE;INTRAVENOUS 203565-001 Jul 25, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,376,505

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany102 49 552Oct 23, 2002

Non-Orange Book US Patents Family Members for Patent 9,376,505

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,612,109 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cerilliant
Boehringer Ingelheim
QuintilesIMS
Queensland Health
Farmers Insurance
Accenture
Deloitte
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.